By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Retrophin, Inc. 

777 Third Avenue
22nd Floor
New York  New York  10017  U.S.A.
Phone: 646-564–3680 Fax:



Company News
Retrophin (RTRX)’s Board Of Directors Appoints John W. Kozarich, Ph.D. As Independent Director And Names Jeffrey A. Meckler As Chairman 4/1/2015 3:44:11 PM
Retrophin (RTRX) Closes Public Offering Of 7,866,000 Shares Of Common Stock And Full Exercise Of Underwriters’ Option To Purchase Additional Shares 3/25/2015 1:18:42 PM
Retrophin (RTRX) Prices Public Offering Of 6,840,000 Shares Of Common Stock 3/19/2015 12:51:08 PM
Retrophin (RTRX) Announces Proposed Public Offering Of 5,100,000 Shares Of Common Stock 3/17/2015 12:13:36 PM
Retrophin (RTRX) Reports Fourth Quarter And Full Year 2014 Financial Results 3/6/2015 7:46:34 AM
Tim Coughlin Joins Retrophin (RTRX)’s Board Of Directors 3/5/2015 11:08:07 AM
Ousted Retrophin (RTRX) CEO Martin Shkreli Launches Turing Pharmaceuticals 2/24/2015 2:40:03 PM
Retrophin (RTRX) To Report Fourth Quarter And Full Year 2014 Financial Results 2/20/2015 11:13:37 AM
Retrophin (RTRX) To Present At The 2015 Leerink Global Healthcare Conference 2/6/2015 12:19:57 PM
Retrophin (RTRX) Announces Voting Results Of Special Meeting Of Stockholders 2/4/2015 9:15:34 AM